The Mix/Bix family of Pax-like homeodomain transcription factors is expressed early in vertebrate development and play important roles in endoderm and mesoderm formation. Like other Pax-related homeodomain proteins, the Mix/Bix family binds DNA as monomers or dimers and dimerization is mediated by the homeodomain. While the Mix/Bix family shares extensive sequence homology within the DNA-binding homeodomain, ectopic expression of these proteins has profoundly different outcomes. Expression of Xenopus Mix.3/Mixer in explanted ectoderm results in endoderm differentiation, whereas Mix.1 expression does not. In this study we sought to define the domains of Mix.3/Mixer that are responsible for this endoderm inducing activity. We generated domain swap mutants between Mix.3/Mixer and Mix.1 and tested their ability to induce endoderm in explanted ectoderm. We demonstrate that the homeodomain and sixty-two amino acids in the carboxyl terminus are required to induce endoderm and that these domains must be on the same polypeptide and can not act in trans as a heterodimer. A Smad2 interaction motif in Mix.3/Mixer is involved in endoderm differentiation but is not essential. Thus, we have defined the regions of Mix.3/Mixer that confer endoderm-inducing activity. These studies reveal a novel co-operation between the homeodomain and a small domain in the carboxyl terminal region that is essential for Mix.3/Mixer function. q
Introduction
Gastrulation results in the establishment of the three germ layers, endoderm, mesoderm and ectoderm. The Mix/Bix family of Pax-like homeodomain transcription factors play important roles in endoderm and mesoderm development that are conserved across vertebrate phylogeny (Pearce and Evans, 1999; Kikuchi et al., 2000; Robb et al., 2000; Hart et al., 2002; Poulain and Lepage, 2002; Kunwar et al., 2003) . In Xenopus laevis, seven members of the Mix/Bix family have been identified (Mix.1, Mix.2, Mix.3/Mixer, Mix.4/Bix.1, Bix.2/ Milk, Bix.3, Bix.4) (Fig. 1A) (Rosa, 1989; Mead et al., 1996; Vize, 1996; Ecochard et al., 1998; Henry and Melton, 1998; Mead et al., 1998; Tada et al., 1998; Casey et al., 1999; Latinkic and Smith, 1999) . These genes are expressed during early development, from mid-blastula stage to the end of gastrulation. Transcripts are localized to distinct regions of the vegetal and marginal zones of the embryo that develop into the endoderm and mesoderm germ layers, respectively. The germ layers are histologically discernable and endoderm cell fate becomes restricted by the end of gastrulation supporting a role for these transcription factors in the establishment of mesoderm and endoderm.
In Xenopus, four members of the family (Mix.3/Mixer, Mix.4/Bix.1, Bix.2/Milk, and Bix.4) are able to induce endoderm tissue when expressed individually in explanted ectoderm (Ecochard et al., 1998; Henry and Melton, 1998; Mead et al., 1998; Tada et al., 1998; Casey et al., 1999) . Mix.3/ Mixer, Bix.1 and Bix.3 have also been shown to induce the transcription of an early endoderm gene, Sox17a (Xanthos et al., 2001; Trindade et al., 2003; Kofron et al., 2004) . Morpholino knock-down of Mix.3/Mixer results in a decrease of endodermal genes Sox17a, Gata-5 and endodermin and an increase in expression of several mesodermal genes (Kofron et al., 2004) . These results indicate a role for Mix.3/Mixer in endoderm development in vivo. Mix.1 and Mix.2, on the other hand, do not play a central role in endoderm development. When expressed alone in explanted ectoderm neither is able to induce endoderm tissue. Mix.1 has been shown to induce endoderm only in co-operation with siamois or goosecoid, two other PAX-like homeodomain proteins Latinkic and Smith, 1999) . In addition, Mix.1 has been shown to antagonize endoderm induction mediated by Mix.3 in explanted ectoderm (Mead et al., 1998) .
To analyze the endoderm specific components of Mix.3 we generated a series of swap mutants between Mix.1 and Mix.3. We focused on these two genes because of their sequence similarity and divergent functions with respect to their ability to induce endoderm. The mutants were tested for their ability to induce endoderm using explanted ectoderm (animal cap) assays. We assayed for late endodermal markers to ensure complete activation of the endoderm pathway as well as early endoderm markers to confirm a role for these mutants in endoderm development. We show that the homeodomain and sixty-two amino acids at the carboxyl terminus of Mix.3 are sufficient for early and late endoderm induction. The Smad2 interaction is involved in endoderm development although it does not appear to be essential. Mix.3 DNA binding is absolutely required for endoderm development. This work has identified the minimal endoderm-inducing domains of Mix.3 and will facilitate the identification of inter-and possibly intra-molecular interactions that are required for endoderm gene induction.
Results

Mix.3 homeodomain and carboxyl terminus co-operate to induce endoderm
Sequence comparison of the Mix family members to Mix.3/Mixer shows that the greatest homology lies within the homeodomain (Fig. 1A) . The homeodomain contains three alpha helices and the third helix (Helix 3, the recognition helix) of the homeodomain makes sequence specific contacts in the major groove of DNA (Wilson et al., 1995) . Among the Mix/ Bix family members helix three is nearly identical implying recognition of the same DNA consensus site. It has been demonstrated in vitro that all of the Mix/Bix proteins, tested to date, bind to the same DNA consensus site (Mead et al., 1996; Mead et al., 1998) . The Mix/Bix proteins bind DNA as monomers or dimers. Dimerization occurs co-operatively on DNA as either homodimers or heterodimers. The interaction on DNA is thought to be stabilized by extensive protein:protein and protein:DNA contacts (Wilson et al., 1995) . All Mix/Bix family members contain acidic residues at the extreme carboxyl terminus of the protein that may function as a transactivation domain. The carboxyl termini, outside of the acidic domain, are highly divergent among the Mix/Bix members (Fig. 1A) .
Mix.3 and Mix.1 swap mutants were generated to identify the domains of Mix.3 that are required for endoderm induction in explanted ectoderm (Fig. 1B) . Mix.1 alone is not able to induce endoderm and served as a negative control in these experiments. Wild-type Mix.3 induces the expression of endoderm genes intestinal fatty acid binding protein (IFABP) and endodermin (edd) in the animal cap assay at stage 35 ( Fig. 2A) . Previous work suggested that the homeodomain might be sufficient for Mix function. A Mix.1 truncation mutant activates transcription from a heterologous promoter in NIH3T3 cells and induces ventral patterning in mesoderm tissue, similar to the full length Mix.1 (data not shown). Mix.3 and Mix.1 were truncated seventeen amino acids after the homeodomain to test the endoderm inducing activity of the homeodomains (M3HD and M1HD, respectively). Neither of these truncation mutants was able to induce endoderm genes ( Fig. 2A) . Mutants in which the c-termini are swapped between Mix.1 and Mix.3 (M113, M331) were also unable to induce the endoderm specific genes (Fig. 2B) . These results indicate that the c-terminus of Mix.3 is required but is not sufficient for endoderm induction.
The homeodomains of Mix.3 and Mix.1 are highly homologous and were swapped to determine whether they were functionally interchangeable. Neither homeodomain swap mutants (M131, M313) was able to induce endoderm markers in the animal cap assay (Fig. 2B ). This suggests that the Mix.3 homeodomain, although very similar to Mix.1, is functionally distinct in its role in endoderm induction. The amino termini of Mix.1 and Mix.3 were swapped (M133, Schematic diagram of the Mix.1 and Mix.3 mutants that were generated to identify the domains of Mix.3 that are involved in endoderm formation. Mix.1 domains are in white while Mix.3 domains are in gray. The homeodomains, amino termini and carboxyl termini were swapped between the two proteins. The nomenclature of the swap mutants indicates the presence of the N-terminal, C-terminal and homeodomain regions of Mix.1 or Mix.3. For example, M131 contains the N-terminus of Mix.1, the Mix.3 homeodomain and the C-terminus of Mix.1. Truncation mutants were generated that deleted the entire carboxyl termini after the homeodomain from Mix.1 (M1HD) and Mix.3 (M3HD) as well as the carboxyl terminal 58 amino acids (M3D58) from Mix.3. HD, homeodomain; SBD, Smad2 binding domain. M311) and only M133 was able to induce endoderm (Fig. 2C) . These results indicate that both the homeodomain and the c-terminus of Mix.3 are required for endoderm induction while the amino terminus is interchangeable. (Mead et al., 1998) . It is possible that the homeodomain and c-terminus of Mix.3 could co-operate between two proteins in complex on DNA. To test whether the homeodomain and carboxyl terminus could co-operate 'in trans' we co-injected mRNA encoding M131, containing the Mix.3 homeodomain, and M313, containing the Mix.3 c-terminus, into the embryos for an animal cap assay. Injection of each mutant alone or together was unable to induce endoderm markers in animal caps suggesting that the homeodomain and c-terminus must be on the same protein to induce endoderm (Fig. 3) .
Mix.3 DNA binding is necessary for endoderm induction
The homeodomains of Mix.1 and Mix.3 are 84% identical with only nine amino acid differences between the two. These two domains, however, are not functionally interchangeable as demonstrated by the lack of endoderm induction by the homeodomain swap mutant M313. To identify the amino acids that are critical for endoderm induction we introduced several mutations into the Mix.3 homeodomain (Fig. 4A) . We individually changed five of the non-conserved amino acid in the Mix.3 homeodomain to the corresponding amino acid in Mix.1 (Y96F, N99A, K100Q, R125H, and E144V). Our initial focus was on residues that were near the DNA-recognition helix, helix 3 of the homeodomain. Valine 135 was changed to alanine, analogous to the bonnie and clyde mutation in Zebrafish that disrupts endoderm development (V135A) (Kikuchi et al., 2000) . Three residues in the middle of helix 3, tryptophan 136, phenylalanine 137 and glutamine 138 were changed to alanines (WFQ-AAA). This mutation was predicted to disrupt DNA binding as crystal structure analysis of a Pax-like homeodomain on DNA indicated that these amino acids make site-specific contact with DNA (Wilson et al., 1995) . All of the helix 3 mutants were tested for DNA binding by eletrophoretic mobility shift assay (Fig. 4C ). The 'bonnie and clyde' mutation (M3V135A) and M3WFQ-AAA mutant were unable to bind the DNA probe. M3R125H and M3E144V bound DNA as monomers and dimers.
The DNA binding defective mutants M3WFQ-AAA and M3V135A did not induce endoderm or were severely compromised for endoderm induction in animal cap experiments (Fig. 4B ). This indicates that DNA binding is required for Mix.3 induction of endoderm. Mutants in helix three that did not disrupt DNA binding (M3R125H and M3E144V) were able to induce endoderm ( Fig. 4B and data not shown). Point mutants outside of helix three (Y96F, N99A, K100Q, R125H) were also able to induce endoderm (data not shown). These results indicate that individually these residues are not critical for endoderm induction and suggest that they play a more subtle role in endoderm induction, possibly by acting cooperatively.
The Smad2 binding domain in Mix.3 is not essential for endoderm induction
Smad2 is an effector of TGF-b signaling and functions by interacting with transcription factors, co-activators or corepressors to regulate the expression of target genes (Itoh et al., 2000) . A Smad2 interaction domain was identified in the carboxyl termini of Mix.3 and Bix.2/Milk and a similar domain was identified in Bix.3 by sequence homology (Germain et al., 2000; Randall et al., 2002) . It was demonstrated that Mix.3 forms a complex with Smad2/Smad4 and this complex was responsible for TGF-b induction of the goosecoid promoter (Germain et al., 2000; Randall et al., 2002) . TGF-b signaling has also been shown to regulate the expression of Mix.3 (Henry and Melton, 1998; Mead et al., 1998) . Activin and Vg1, two TGF-b molecules, as well as Smad2 induce the expression of Mix.3. This suggests a feed-forward regulatory loop in which TGF-b signaling regulates the expression of Mix.3 through activation of Smad2 and Mix.3 in turn regulates the expression of other genes through interaction with Smad2.
We mutated the Smad2 binding domain in Mix.3 (M3QTN) and added a Smad2 binding domain to Mix.1 (M1PPT). The interaction of these mutants with Smad2 was confirmed using a yeast two-hybrid system (Fig. 5A ). The Mix genes fused to the Gal4 activation domain were co-expressed with Xenopus Smad2 fused to Gal4 DNA binding domain. Yeast expressing wild type Mix.3 and M1PPT, containing the Smad2 binding domain, were able to grow on 'four drop out' ( Fig. 5A ; 4DO) selection media, indicating an interaction with xSmad2. Mix.1 and M3QTN were not able to grow under these selective conditions indicating they are not able to interact with xSmad2. As a control for yeast viability we demonstrated that each of the strains grew on the non-selective 'two drop out' media ( Fig. 5A ; 2DO).
We tested these mutants for induction of early and late endoderm markers in animal caps to assess the requirement of the Smad2 interaction. Mutation of the Smad2 binding domain in Mix.3 (M3QTN) does not disrupt its ability to induce IFABP in stage 35 animal caps (Fig. 5B) . Addition of the Smad2 interaction domain to Mix.1 (M1PPT) does not enable this modified protein to induce IFABP. High amounts of RNA (1 ng) were injected for these assays and we were concerned that a mutant with attenuated activity may not be detectable under these conditions. To address this, animal cap experiments were done using lower amounts of injected RNA (0.5 and 0.1 ng) and assaying for the late endoderm marker endodermin by Real-time RT-PCR (Fig. 5C ). M3QTN and wild-type Mix.3 induced high amounts of endodermin when 0.5 ng of RNA was injected and similar, but lower amounts, when 0.1 ng was injected. At these concentrations of injected RNA we were not able to detect a difference in activity of the mutant compared to the wild type for induction of endodermin. To further explore the activity of this mutant we performed a dose response using Mix.3 and M3QTN RNA in stage 11.5 animal caps and assayed for an early endoderm marker, Sox17a (Fig. 5D) . At the lowest concentration of injected RNA (0.1 ng), Mix.3 induced approximately 7-fold more Sox17a than M3QTN. However, at higher concentrations of RNA (0.5 and 1 ng) the fold difference was less than 2. These data suggest that M3QTN is attenuated for induction of Sox17a and higher amounts of RNA are able to overcome this defect. The ability of M3QTN to overcome this defect at higher amounts of RNA may explain the induction of late endoderm development by this mutant.
The acidic domain and the homeodomain of Mix.3 are sufficient for endoderm induction
The Mix/Bix proteins all contain a conserved sequence of acidic residues at the extreme carboxyl termini that could potentially function as a transcriptional activation domain. We deleted this domain from Mix.3 by engineering a stop codon that removes the last fifty-eight amino acids (M3D58) but retains the Smad2 binding domain. Deletion of this domain destroys Mix.3 endoderm inducing activity in animal cap assays (Fig. 6A) . Our data indicates that the homeodomain and c-terminus of Mix.3 co-operate to induce endoderm. We constructed additional mutants to test whether the acidic domain of Mix.3 was sufficient to co-operate with the homeodomain (Fig. 6B ). We started with the Mix.1 swap mutant that contains the Mix.3 homeodomain (M131) and replaced the last fifty-nine amino acids of the Mix.1 c-terminus with the last sixty-two amino acids of Mix.3 (M131.3). As a control, the last sixty-two amino acids of Mix.3 were replaced with the last fifty-nine amino acids of Mix.1 (M333.1). In animal cap assays M131 and M333.1 are unable to induce endoderm indicating that the Mix.1 acidic domain in the carboxyl terminus is not sufficient for endoderm induction (Fig. 6B ). M131.3 is able to induce endoderm in the animal cap assays indicating that the Mix.3 acidic domain is uniquely required to co-operate with the homeodomain to induce endoderm.
We next examined these mutants for their ability to induce early endoderm markers, Sox17a and Darmin (Fig. 7) . RNA (0.1 ng) was injected, caps were harvested at stage 11.5 and real time PCR was used to quantitate cDNA levels. M333, M131.3 and wild type Mix.3 induce Sox17a and Darmin compared to uninjected caps while M111, M131, M333.1 and M3QTN did not induce these early markers. The induction of early endoderm markers correlates with the induction of late endoderm markers with the exception of M3QTN (described in Fig. 5) . Mutation of the Smad2 binding domain attenuates Mix.3 activity suggesting that this domain is involved in, but is not absolutely required for, induction of endoderm. The M131.3 swap mutant induces both early and late endoderm markers and does not contain a Smad2 interaction domain (Figs. 6B and 7A,B) . This suggests that the homeodomain and sixty-two amino acids at the carboxyl terminus (acidic domain) of Mix.3 are sufficient for induction of endoderm.
The DNA binding activity of these domain swap mutants was tested by electrophoretic mobility shift assay (EMSA) (Fig. 8A) . In vitro transcribed and translated swap mutant proteins were able to bind the consensus P3 site as monomers and dimers. M131 and its derivative, M131.3, appear to bind DNA preferentially as dimers over monomers. This result demonstrates that the DNA binding capability of these mutants was not disrupted in the generation of these mutants. We also tested these domain swap mutants for transcriptional activity using the dual luciferase reporter assay (Fig. 8B) . We used a luciferase reporter driven by a minimal promoter (TATA box) and three-tandem Mix dimer binding sequences (P3luc) together with a renilla reporter as an internal control (pRL-TK). The reporter plasmids were injected alone (P3luc/ pRL-TK) or together with Mix mRNA into single-cell fertilized embryos and harvested at stage 11 for luciferase assays. Wild type Mix.1 and Mix.3 (M111 and M333) as well as several swap mutants (M333.1, M131, M313) showed similar levels of transcriptional activity (Fig. 8B) . Surprisingly M131.3, which was active for endoderm induction, showed the lowest level of transactivation. These results demonstrate that all of the domain swap mutants are transcriptionally active albeit it at different levels. Furthermore high-level transcriptional activation in this system does not correlate with the ability to induce endoderm.
Mix.3 suppression of brachyury is independent of endoderm induction
Mix.3 has been shown to inhibit the expression of several mesoderm genes as well activate the expression of several endoderm genes (Kofron et al., 2004) . Ectopic expression of Mix/Bix genes including Mix.1, Bix.1 and Bix.2, have been shown to block the expression of the mesoderm gene brachyury Tada et al., 1998; Ecochard et al., 1998) . To explore Mix.3 repression of mesoderm we examined the effect of ectopic expression of our Mix.3 mutants on expression of brachyury. We injected Mix.3, M3D58, M3QTN and M3WFQ RNA into embryos together with a linage tracer and examined brachyury expression by in situ hybridization (Fig. 9) . All of the Mix.3 RNAs, with the exception the DNA binding defective mutant M3WFQ, block brachyury expression in the medial domain of stage 11.5 embryos. This demonstrates repression of a mesoderm marker by Mix.3 that is dependant on the DNA binding activity of Mix.3. The acidic domain and the Smad2 binding domain are not required for inhibition of brachyury expression.
Mix.3 mutants ventralize or induce endoderm in whole embroyos
Injection of Mix.1 mRNA results in ventralization of the whole embryo as seen by expansion of ventral mesoderm tissue and loss of head and tail structures (Mead et al., 1996) . Mix.3 mRNA also causes a loss of head and tail structures but endoderm tissue is expanded as revealed by in situ analysis for endodermin expression (Mead et al., 1998) . We injected a series of Mix.3 mutants into single cell embryos and stained them for expression of endodermin (edd) by in situ hybridization at stage 38 (Fig. 10 ). Embryos injected with M111 (10B), M131 (10D), and M313 (10F) mRNA expressed endodermin in similar patterns and to similar levels as uninjected embryos. The embryos also appeared ventralized with stunted head and tail development. M333 (10C) and M131.3 (10E) injected embryos mis-expressed patches of endodermin throughout the embryo. The head and tail structures of all of these embryos were also reduced. These results demonstrate that the swap mutants that were able to induce endoderm in the animal cap assay are also capable of inducing endoderm in the whole embryo. Furthermore, the mutants negative for endoderm induction in the animal cap assays appear to retain the ability to pattern mesoderm in the whole embryo, evidenced by the suppression of head and tail structures. These results indicate that the mutants retained in vitro and in vivo functions of the wild-type Mix.1 and Mix.3. 3 responsive promoter, which contained three P3 sites and a minimal promoter (TATA box), driving luciferase gene expression (P3luc) was co-injected with a Renilla luciferase internal control plasmid (pRL-TK) either with or without Mix synthetic mRNA. Pools of embryos were harvested at stage 11 and assayed for luciferase activity. Luciferase activity was normalized to embryos injected with reporter constructs without Mix mRNA. Shown is the combined average of three separate experiments. All of the mutants show some transcriptional activity although high-levels of activity do not correlate with endoderm induction. 
Discussion
The aim of this study was to identify the molecular determinants of endoderm induction by the homeodomain protein Mix.3. We used a structure/function approach to identify the critical domains of Mix.3 that are required for endoderm-inducing activity. The closely related family member, Mix.1, was used as our null control. Although Mix.1 shares extensive sequence similarity with Mix.3, it is unable to induce endoderm in naïve ectoderm. A series of Mix.1:Mix.3 chimeric proteins was generated and tested in animal cap assays for their ability to induce the expression of early and late endoderm-specific marker genes. This approach has revealed that two domains of Mix.3 are sufficient for endoderm induction: sixty-two amino acids at the carboxyl terminal (the acidic domain) and the homeodomain of Mix.3. These two Mix.3 domains, in the context of a Mix.1 'backbone', are able to induce the expression of early and late endoderm marker genes in animal cap assays and cause the expansion of endoderm tissue in whole embryos.
A Smad2 binding domain was identified in Mix.3 (and Bix.2/Milk) and shown to be necessary for TGF-b transcriptional regulation of the goosecoid promoter (Germain et al., 2000; Randall et al., 2002) . A similar domain was identified by sequence homology in Bix.3; however, Mix.4/Bix.1, Bix.4 and Mix.1 do not contain this domain. Both Mix.3 and Bix.2/Milk are able to induce endoderm in explanted ectoderm and we tested whether Smad2 binding was involved in this activity. Mutation of this domain in Mix.3 impaired early endoderm marker induction when injected at low doses. Over-expression of the mutant at higher doses could overcome the impairment and induce both early and late endoderm markers. This suggests that the Smad2 binding domain is playing a role in Mix.3 endoderm induction but is not essential for this activity. Results obtained with the M131.3 mutant support the conclusion that the Smad2 binding domain is not essential for Mix.3-directed endoderm induction. This mutant contains the Mix.3 homeodomain and the Mix.3 carboxyl terminal acidic domain on a Mix.1 'backbone' that lacks the Smad2 interaction domain yet efficiently induces early and late endoderm markers at low and high injection doses.
The acidic domain of Mix.3 has no predicted secondary structure and we have been unable to identify protein interaction motifs that are critical for endoderm development. We noticed a potential HP1 binding site in the acidic domain of Mix.3 that was not found in Mix.1. This motif (PxVxM/L/V) was found in several HP1 binding proteins and was shown to be critical for their interaction with HP1 (Murzina et al., 1999; Smothers and Henikoff, 2000) . Mutation of this sequence in Mix.3 did not disrupt endoderm induction in animal caps (data not shown) suggesting that this potential interaction motif is dispensable for endoderm induction.
Although the acidic domains of the Mix/Bix family are conserved the Mix.3 acidic domain is the most divergent in the family. Mix.4/Bix.1, Bix.2/Milk, and Bix.4 induce endoderm in explanted ectoderm even though their acidic domains are different from Mix.3. This suggests that the Mix.3 acidic domain may function differently from other Mix/Bix acidic domains in endoderm induction. Trindade and co-workers (Trindade et al., 2003) have reported an intriguing result on the induction of apoptosis by Bix.1 and Bix.3. They identified an apoptosis-inducing domain in Bix.1 that is negatively regulated by the acidic domain. They show that the inhibitory activity of the acidic domain resides, in part, on threonine 384. The Mix.1 acidic domain is very similar to Bix.1 and contains a threonine at the 384 equivalent position. Mix.3 on the other hand contains a glycine at this position although the adjacent amino acids are conserved. This raised the possibility that the Mix.1 carboxyl terminus and acidic domain fusions (M131 and M333.1) could inhibit some function of Mix.3. However, we do not believe that this domain inhibits Mix.3 endoderm induction. Our truncation mutant Mix.3D58 has proven that the carboxyl terminal fifty-eight amino acids of Mix.3 are essential for endoderm induction. In addition we have mutated threonine 384 to glycine in the Mix.1 carboxyl terminus of M333.1 and this mutant is still unable to induce endoderm. Furthermore we have changed the glycine in Mix.3 to threonine and this mutant is able to induce endoderm (data not shown). Together these results suggest that this domain is unable to interfere with Mix.3 induction of endoderm.
Surprisingly, the homeodomains of Mix.1 and Mix.3 were shown to be functionally distinct in their ability to induce endoderm in explanted ectoderm. Swapping the homeodomain of Mix.3 with the Mix.1 homeodomain disrupted the ability of Mix.3 to induce endoderm in animal caps and whole embryos. The two domains share 85% amino acid sequence identity with only five non-conserved amino acid differences. The DNA binding domain, helix three of the homeodomain, is nearly identical in the two proteins and both proteins bind to the same oligonucleotide in electrophoretic mobility shift assays (Mead et al., 1998) . Mutants of Mix.3 in helix 3 that disrupt DNA binding are unable to induce endoderm indicating that DNA binding is required for endoderm induction. Mutations in the homeodomain that did not disrupt DNA binding were still able to induce endoderm suggesting that individually these residues are not critical for Mix.3 function. These residues may act cooperatively to enable the Mix.3 homeodomain to induce endoderm.
A feature of the Pax-like homeodomain proteins is their ability to dimerize on DNA. We tested whether the two endoderm-inducing domains of Mix.3 could act in trans. Coexpression of constructs with the Mix.3 homeodomain and the c-terminal domain on separate polypeptide chains did not result in endoderm gene expression. This indicates that both domains must be present on the same peptide and may indicate that the two domains must be presented in a specific orientation on DNA to recruit accessory proteins that form an endoderminducing transcriptional complex.
Mix.3 has been shown to repress the expression of the mesoderm genes Bix.1, FGF8 and eomesodermin (Kofron et al., 2004) . We examined the ability of Mix.3 to repress mesoderm and tested several of our mutants to determine if this activity correlates with endoderm induction. We demonstrate that ectopic expression of Mix.3 blocks the expression of brachyury in whole embryos and this activity is dependent on DNA binding. Mutants defective for endoderm induction (e.g. M3D58) were also able to repress brachyury. This suggests that the two activities of Mix.3, endoderm induction and brachyury repression, are separable and that the carboxyl terminal domain required for endoderm induction is distinct from the domain(s) required for brachyury repression.
This work identifies two relatively small domains in Mix.3 that are necessary and sufficient for endoderm induction. In order to understand the mechanism of Mix.3 induction of endoderm it was necessary to isolate endoderm specific domains from domains that are involved in mesoderm patterning only, an activity shared by Mix.1. Using these domains we will be able to identify the interacting proteins and/or intramolecular interactions that are critical for regulation of endoderm specific gene transcription.
Experimental procedures
Mix mutants
Mix.1 and Mix.3 cDNAs were isolated from an expression library of stage 11 ventralized embryos (Mead et al., 1998) . The cDNA for the library was directionally cloned into pCDNA3 (Invitrogen, CA) using EcoRI and NotI sites. Mutations were introduced into the Mix genes using Statagene's QuikChange Site-Directed Mutagenesis Kit according to the manufacturers instructions. All mutant constructs were completely sequenced to ensure that PCR induced errors were not introduced during the mutagenesis step. Truncation mutants were created by adding stop codons seventeen amino acids downstream of the homeodomain (M1HD, M3HD) and fifty-eight amino acids upstream of the carboxyl terminal end of Mix.3 (M3D58). Swap mutants were designed by adding a ClaI restriction site seven amino acids upstream and a KpnI restriction site four amino acids downstream of the homeodomains in Mix.1 and Mix.3. Single amino acid changes were introduced in the wild type genes by these restriction sites and the altered genes were called M111 and M333 to reflect this change. The addition of the restriction sites had no effect on the function of the two proteins. The amino termini (including 5 0 untranslated regions), homeodomains and carboxyl termini (including 3 0 untranslated regions) were isolated following appropriate restriction endonuclease digests from one gene and ligated into the reciprocal gene to create the domain swap mutants. SacII sites were introduced sixty-two amino acids upstream of the carboxyl terminal end of M333 and fifty-nine amino acids upstream of the carboxyl terminal end of M111. The Mix.3 carboxyl terminal was swapped onto M131 to generate M131.3 and the Mix.1 carboxyl terminal was swapped onto M333 to generate M333.1. The addition of the SacII sites had no affect on the activity of the resultant mutants (data not shown). The Smad2 binding domain was mutated in Mix.3 by changing the consensus PPNKT motif at amino acids 291-295 to QTNKN, the amino acids found at the corresponding site in Mix.1. Likewise, the QTNKN sequence at amino acid 300-304 in Mix.1 were changed to PPNKT to create a Smad2 binding site.
Xenopus embryo manipulations
Xenopus laevis embryos were obtained, fertilized and microinjected as described in Early Development of Xenopus laevis (Sive et al., 2000) . Briefly, female frogs were induced to lay eggs by gonadotropin injection, fertilized in vitro with macerated testis and de-jellied with 0.3% (w/v) cysteine hydrochloride. Single cell, fertilized embryos were injected with mRNA synthesized with mMessage mMachine transcription kit (Ambion, TX). The upper one third of pigmented region, the animal cap, was excised from stage eight embryos using a hair loop and cultured in 0.5X MMR, 0.5% (w/v) bovine serum albumen, penicillin (100 units/ml) and streptomycin (0.1 mg/ml) (1X MMRZ100 mM NaCl, 2 mM KCl, 1 mM MgSO 4 , 2 mM CaCl 2 , 5 mM HEPES, pH 7.6, 0.1 mM EDTA). Animal caps from at least twenty embryos per RNA were dissected at stage 8 and cultured at 18 8C until sibling embryos had reached either stage 11.5 for early endoderm (roughly 12 h) or stage 35/36 for late endoderm (5 days). Total RNA was extracted from caps using RNAeasy Mini Prep Kit (Qiagen, CA) and reverse transcribed using SuperScript II Reverse Transcriptase (InVitrogen, CA) and oligo dT primers.
4.3.
32 P PCR and real time PCR
Endoderm specific genes were amplified from cap cDNA using HotStar Taq DNA polymerase (Qiagen, CA) and primers specific for endodermin (edd) P-dCTP was included in the reaction to allow detection of the PCR product by autoradiography. Reactions were separated on pre-cast 10% (w/v) polyacrylamide Tris-Borate-EDTA gels (Bio-Rad), fixed, dried and exposed to X-ray film. Each animal cap experiment was repeated at least three times.
Real time PCR was done using iQ SYBR Green Supermix (Bio-rad), run and detected using an iCycler thermocycler (Bio-rad). Primers specific for A standard curve was generated for each primer pair using serially diluted cDNA from uninjected whole embryos. Relative expression values were calculated by comparison to the standard curve and normalized to the relative level of ODC. Each reaction was run in duplicate and the standard deviation of the quotient is calculated from the standard deviations of the experimental relative mean and the ODC relative mean (described in Applied Biosystems ABI prism 7700 sequence detection system, user bulletin #2). A single representative real-time experiment of three is shown.
In situ hybridization of whole embryos
Whole embryo in situ hybridization was performed using albino embryos as described by Harland (Harland, 1991) . Anti-sense probes were generated as described by Kelley et al. (Kelley et al., 1994) . Briefly, anti-sense probes were synthesized with digoxigenin-coupled UTP (Roche) and detected with alkaline phosphatase coupled to anti-digoxigenin Fab fragments (Roche) followed by the chromogenic reaction with BM Purple (Roche). b-galactosidase RNA injected embryos were stained after fixation with Red-gal (Research Organics) according to the manufacturers directions.
Yeast two hybrid assay
The MatchMaker 3 system (Clontech, CA) was used to demonstrate the interaction of Mix.3 and M1PPT with Xenopus Smad2. The Mix genes were subcloned into pGADT7 vector to generate fusion proteins with the Gal4 activation domain. Xenopus Smad2 was subcloned into the pGBKT7 vector to generate a fusion with the Gal4 DNA binding domain. The Mix constructs were co-transfected with the Smad construct into yeast strain AH109 and cultured on two drop-out (minus leucine and tryptophan) and four drop-out (minus leucine, tryptophan, adenine and histidine) selection agar plates.
Luciferase reporter assay
A Mix.3 responsive luciferase reporter construct (P3luc) was generated by cloning three tandem Mix binding sites (P3ZTAATTGAATTA) together with the herpes simplex virus thymidine kinase minimal promoter (TATA box) into the pGL3-basic luciferase vector (Promega, WI). The Renilla luciferase reporter (pRL-TK, Promega, WI) was used as an internal control. Single cell embryos were microinjected with 100 pg of luciferase reporter, 50 pg of pRL-TK, and 0.5 ng of synthetic Mix mRNA. Embryos were harvested at stage 11 and assayed using reagents from the Dual Luciferase Reporter Assay System (Promega, WI). Luciferase activity was measured in a Zylux Femtomaster FB12 luminometer. In each experiment three sets of 10 embryos were assayed for each condition and four separate experiments were averaged.
Electrophoretic Mobility Shift Assay (EMSA)
EMSA was carried out as described in Mead et al. (1996) using Mix DNA binding domain P3 (TAATTGAATTA) (Mead et al., 1996) . Proteins were in vitro transcribed and translated using TnT coupled Reticulocyte Lysate System (Promega, WI).
